Definium Therapeutics (DFTX)Chief Accounting Officer sold ~$16K

~$16K

Approx. value · 2,347 sh @ $6.74

145K

Holds after · shares reported

Traded

Mar 25, 2025

Filed

Mar 26, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 25, 2025 · this disclosureInsiderOfficer sold ~$16K of DFTX shares in the open market

What came next

1. Mar 25, 2025Insider · 3 peopleInsiders: 3 sales (~$233K)
2. Jun 25, 2025Insider · 3 peopleInsiders: 3 sales (~$312K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Definium Therapeutics

For Definium Therapeutics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 8 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DFTX page.

Other recent filings by Carrie Liao, Chief Accounting Officer

• SEC Form 4 at Definium Therapeutics (DFTX)Dec 27, 2024

The full history of Carrie Liao, Chief Accounting Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Definium Therapeutics

• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its DFTX page.